amgen has launched two pivotal late-stage trials for maritide, an experimental weight loss drug aimed at entering the growing obesity treatment market, competing against other products from novo nordisk and eli lilly.
Annika Kim Constantino
03/05/2025 12:00:00 AM
Health

198 views
Happiness 😊
Happiness 😊 - 60%
Anger 😡 - 10%
Surprise 😲 - 30%
Mentions in context

😊 Happiness
amgen is conducting late-stage trials for its weight loss drug maritide.
😊 Happiness
maritide is amgen's experimental weight loss injection currently in late-stage trials.
😊 Happiness
amgen's executive vice president of research and development, spoke about the trials.

😨 Fear
novo nordisk produces existing weight loss drugs that maritide aims to compete against.
😨 Fear
eli lilly also manufactures weight loss drugs that compete with maritide.